RZG
Invesco S&P Smallcap 600 Pure Growth ETF
Invesco S&P Smallcap 600 Pure Growth ETF is an exchange-traded fund incorporated in the USA. The Fund's objective is to replicate as closely as possible, before expenses, the performance of the S&P Smallcap 600/Citigroup Pure Growth Index.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 112.4 M
ASSETS UNDER MGMT
35 bp
EXPENSES
Fund Basics
| Inception date | Mar 01, 2006 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| PROTAGONIST THERAPEUTICS, INC. | 2.1 % |
| ARCUTIS BIOTHERAPEUTICS INC | 2.1 % |
| OM ASSET MANAGEMENT PLC | 2.0 % |
| DAVE INC ORDINARY SHARES - CLASS A | 1.8 % |
| CHEFS' WAREHOUSE INC/THE | 1.7 % |
| DXP ENTERPRISES INC | 1.6 % |
| ACM RESEARCH, INC. CLASS A | 1.5 % |
| PROGYNY, INC. | 1.5 % |
| TG THERAPEUTICS INC | 1.5 % |
| CLEAR SECURE, INC. CLASS A | 1.4 % |
Constituent Breakdown
| Number of holdings | 129 |
| Herfindahl-Hirschman Index | 107 |
| Wgt avg mkt cap (mns) | $3,602 |
| Large cap (>$10bn) | 75.9% |
| Mid cap ($2-10bn) | 15.9% |
| Small cap (<$2bn) | 0.0% |
| Developed mkts. | 93.8% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 91.1 % |
 |
BERMUDA | 1.4 % |
 |
BAHAMAS | 1.0 % |
 |
IRELAND | 0.7 % |
Historical Performance
Standardized Performance (as of 09/30/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 14.9% | 14.7% | 10.2% | 15.8% | 3.3% | 7.7% | 8.4% | 8.0% |
| Dividend Yield | 0.6% | 0.7% | 0.6% | 0.9% | 1.1% | 0.8% | 0.7% | 0.6% |
| Total Returns | 15.5% | 15.4% | 10.8% | 16.6% | 4.3% | 8.5% | 9.0% | 8.7% | Ann. Volatility | 19.3% | 19.0% | 21.6% | 21.0% | 23.0% | 24.7% | 24.4% | 24.3% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.12 | 58% |
| MSCI EAFE | 0.88 | 53% |
| MSCI Emg Mkts | 0.50 | 44% |
Liquidity Measures
| Avg. volume (000) | 3 |
| ADV traded (mns) | $0 |
| Turnover | 0.2% |
| Avg. Bid/Ask (% of price) | 0.34% |
Technical Indicators
| 30d moving avg. (EMA) | $62.95 |
| Relative strength (RSI) | 43 |
| MACD/Signal | -0.44/-0.59 |
| Bollinger Bands (Upper/Lower) | $63.39/$61.23 |
| Short interest (% of AUM) | 0.6% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. RZG |
Expenses vs. RZG |
ALTAR Score™ vs. RZG |
|---|---|---|---|---|
| SLYG | State Street SPDR S&P 600 Small Cap Growth ETF | 46.1% | -20 bp | +1.2% |
| IJT | iShares S&P Small-Cap 600 Growth ETF | 45.5% | -17 bp | +1.1% |
| VIOG | Vanguard S&P Small-Cap 600 Growth ETF | 41.8% | -25 bp | +0.7% |
| GRPZ | Invesco S&P SmallCap 600 GARP ETF | 35.2% | 0 bp | +3.1% |
| XSHQ | Invesco S&P SmallCap Quality ETF | 27.2% | -6 bp | +2.9% |
| CAFG | Pacer US Small Cap Cash Cows Growth Leaders ETF | 24.3% | +24 bp | +3.3% |
| XSMO | Invesco S&P SmallCap Momentum ETF | 24.1% | 0 bp | +0.8% |
| XJR | iShares ESG Screened S&P Small-Cap ETF | 23.9% | -23 bp | +3.2% |
| SPSM | State Street SPDR Portfolio S&P 600 Small Cap ETF | 23.4% | -32 bp | +3.9% |
| IJR | iShares Core S&P Small Cap ETF | 23.0% | -29 bp | +3.8% |
Risk and Returns: RZG vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 11/6/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
3.5%
ALTAR SCORE™
15th
PERCENTILE
AVOID
ETFRC RATING
There are 1,388 funds in the US Equity category with an average
ALTAR Score™ of 5.7% and a standard deviation
of 2.1%. RZG's ALTAR Score™ is approximately -1.0 standard
deviations above the category average. This places RZG in the 15th percentile
among funds in the category.
Sell-Side Consensus
$80.26
PRICE TARGET
+34.5%
UPSIDE